Drug（薬物リスト） DrugBank | All Description Patterns💬 Info on mouse-over
| No. | 薬物名（臨床試験情報から抽出） | DrugBank | KEGG DRUG | KEGG GENES | KEGG PATHWAY On map, Yellow: Drug target genes |
指定難病告示番号 |
| 1 | Bmn 110 | - | - | - | - | 019 1件: 19 💬 |
| 2 | Bmn 110 - every other week | - | - | - | - | 019 1件: 19 💬 |
| 3 | Bmn 110 - weekly | - | - | - | - | 019 1件: 19 💬 |
| 4 | Bmn 110 every other week | - | - | - | - | 019 1件: 19 💬 |
| 5 | Bmn 110 weekly | - | - | - | - | 019 1件: 19 💬 |
| 6 | Recombinant human n-acetylgalactosamine 6-sulfatase, bmn 110 | - | - | - | - | 019 1件: 19 💬 |
| 7 | Recombinant human n-acetylgalactosamine 6-sulfatase, bmn 110 drug substance | - | - | - | - | 019 1件: 19 💬 |
| 8 | Recombinant human n-acetylgalactosamine-6-sulfatase, bmn 110 | Elosulfase alfa | 1件: D10333 D10333 💬 |
GALNS 1件: GALNS 💬 |
Glycosaminoglycan degradation 3件: Glycosaminoglycan degradation, Lysosome, Metabolic pathways |
019 1件: 19 💬 |
| 9 | Recombinant human n-acetylgalactosamine-6-sulfatase, bmn 110 drug substance | Elosulfase alfa | 1件: D10333 D10333 💬 |
GALNS 1件: GALNS 💬 |
Glycosaminoglycan degradation 3件: Glycosaminoglycan degradation, Lysosome, Metabolic pathways |
019 1件: 19 💬 |